ALS stock trades at AUD 21.05 as FY27 growth takes shape

Published on 10/07/2026 at 05:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ALS stock was trading at AUD 21.05 on October 7, 2026, while FY26 revenue rose 10.7 percent. Analysts cite an average AUD 24.28 target from 13 ratings.

ALS, AU000000ALQ6, Illustration mit AI erstellt.

ALS stock was trading at AUD 21.05 on the ASX on October 7, 2026, up 0.67 percent from the previous close, with 181,775 shares changing hands. The latest investor debate centers on whether the company's FY27 growth outlook can justify its valuation.

FY26 growth sets the baseline

According to The Motley Fool Australia on September 15, 2026, ALS reported FY26 revenue growth of 10.7 percent, underlying operating profit growth of 19.3 percent and underlying net profit after tax growth of 25.8 percent. Those figures give investors a concrete starting point for judging the company's next phase.

The same report said ALS had started FY27 on track for high-single-digit organic revenue growth and margin improvement consistent with FY26. Commodities organic revenue growth was above the company's 15 percent to 17 percent first-half guided range, while Life Sciences growth had improved from the second half of FY26 but remained below mid-single-digit expectations.

Consensus leaves a valuation gap

The analyst picture is positive but still leaves a measurable hurdle. MarketScreener lists an Outperform mean consensus from 13 analysts and an average target of AUD 24.28. That target lies 15.37 percent above the October 7 price of AUD 21.05.

The market is therefore weighing two different signals: double-digit FY26 profit growth and a share price that remains below the 52-week high of AUD 26.17. The current price is AUD 1.77 above the 52-week low of AUD 19.28, leaving the stock 19.58 percent below its yearly peak.

Results date gives investors a checkpoint

ALS operates through its Commodities and Life Sciences businesses, providing testing, measurement and inspection services across mining, environmental, food and pharmaceutical markets. ALS Limited identifies ASX:ALQ and presents FY26 results materials on its investor-relations site.

The next scheduled results release is November 23, 2026, according to MarketScreener. That date should provide the next formal test of organic growth, margin improvement and the split between commodities and life sciences demand.

ALS stock trades below its high

ALS stock was last at AUD 21.05 on the ASX on October 7, 2026 at 2:21 p.m. AEDT. Its market capitalization was AUD 10.7 billion, and the 52-week range stood at AUD 19.28 to AUD 26.17.